Immunology and Virology Diseases

New Generations Vaccine Adjuvants

Vaccine adjuvants were first reported about 80 years ago and have been utilized to improve immune responses against non-living vaccines since then. Adjuvants are included in vaccines to improve immune responses to vaccine antigens. Viral infectious diseases represent a major portion of global public health concerns with thousands of demise annually. Adjuvants are immune potentiators administered concurrently with antigens in order to increase the vaccine effectiveness. These new-generation vaccine adjuvants massively work by activating the local innate immune system to trigger the antigen-specific immune response. The necessity for vaccine adjuvants was established after the discovery of safe, highly purified, but less immunogenic, synthetic antigens via innovation in recombinant DNA technology.